Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the clinical response to daily Indinavir oral
administration in association with a conventional chemotherapy based on cycles of systemic
Vinblastine +/- Bleomycin in patients affected by advanced classical (non HIV-associated)
Kaposi's sarcoma
Phase:
Phase 2
Details
Lead Sponsor:
Barbara Ensoli, MD, PhD
Treatments:
Bleomycin HIV Protease Inhibitors Indinavir Protease Inhibitors